1Pissarek M,Bigard X, Mateo P,et al. Adaptation of cardiac myosin and creatine kinase to chronic hypoxia:Role of anorexia and hypertension[J]. Am J Physiol,1997,272(4 pt 2) :1690 -1695.
2Schwartz K, Carrier L, Mercadier J, et al. Molecular phenotype of the hypertrophied and failing myocardium[J]. Circulation, 1993,87 (Suppl VII) : 5-10.
3Sakurai S, Ashida T, Ieki K, et al. Left ventricular regional variatins in myosin shiftin Dahl salt-sensitive hypertensive rats [J]. Hypertens Res, 2003,26 (3) : 251-255.
4Malkiel S, Kuan AP, Diamond B. Autoimmunity in heart disease: Mechanisms and genetic susceptibility[J].Mol Med Today, 1996,2 (8) ,336-342.
5Rai TS, Ahmad S, Ahluwalia TS,et al. Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy[J].Mol Cell Biochem,2009,331(1-2) :187-192.
6Asakura M,Kitakaze M. Global gene expression profiling in the failing myocardium[J].Circ J,2009,73(9) :1568-1576.
2LAUER B,SCHANNWELL M,KHL U,et al.Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis[J].J Am Coll Cardiol,2000,35(1):11-18.
3STAUDT A,BOHM M,KNEBEL F,et al.Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy[J].Circulation,2002,106(19):2 448-2 453.
4JOHNS T N P,OLSON B J.Experimental myocardial infarction.A Method of coronary occlusion in small animals[J].Ann Surg,1954,10(5):675-682.
6MALKIEL S,FACTOR S,DIAMOND B.Autoimmune,myocarditis does not require B cells for antigen presentation[J].J Immunol,1999,163(10):5 265-5 268.
7KAMRADT T,MITCHISON N A.Tolerance and autoimmunity[J].N Engl J Med,2001,344(9):655-664.
8PRETE G F,CARLI M,RICCI M,et al.Helper activity for immunoglobulin synthesis of T helper type 1(Th1) and Th2 human T cell clones:the help of Th1 clones is limited by their cytolytic capacity[J].J Exp Med,1991,174:80-91.
9AFANASYEVA M,WANG Y,KAYA Z,et al.Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype[J].Am J Pathol,2001,159(1);193-203.
2Dickstein K, Cohen-solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology [J]. Eur J Heart Fail,2008,10(10): 933-989.
3BristowMR, Saxon LA, Boehmer J, et al. Cardiac-resynch-ronization therapy with or without an implantabledefibrillator in advanced chronic heart failure for thecomparison of medical therapy, pacing, and defibrillation inheart failure (COMPANION) investigators [J]. N Engl JMed,2004,350(21): 2140-2150.
4Leeker GB, SchalijMJ, Molhoek SG, et al. Relationshipbetween QRS duration and left ventricular dyssynchrony inpatients with end-stage heart failure[J]. J CardiovascElectrophysiol, 2004, 15(5): 544-549.
5Haghjoo B, Faijam F. Prevalence of mechanical dyssynch-rony in heart failure patients with different QRS durations[J].PACE, 2007, 30(5): 616-622.
6Hung ES, Leon AR,Tavazzi L, et al. Results of thepredictors of response to CRT (PROSPECT) trial [J].Circulation, 2008’ 117(20): 2608-2616.
7Otrim C,Simes O, Loureiro MJ, et al. Acute resynch-ronization with inhaled iloprost in a pregnant woman withidiopathic pulmonary artery hypertension[J]. Rev PortCardiol, 2006,25(5): 529-533.
8Florea VG, Fisher L. Surrogate end points in heart failure[J].J Am Coll Cardiol, 2002, 39(9): 1414-1421.
9YpenburgC, van Bommel RJ, Borleffs CJ, et al. Long-termprognosis after cardiac resynchronization therapy is relatedto the extent of left ventricular reverse remodeling at midtermfollow-up[J]. J Am Coll Cardiol, 2009,53(6): 483-490.
10Luedorff G, Grove R, Kranig W, et al. Different venousangioplasty manoeuvers for successful implantation of CRTdevices[J]. Clin Res Cardiol, 2009, 98(3): 159-164.
